 Immediate postoperative aspirin graft patency coronary artery bypass graft surgery placebo-controlled study BACKGROUND efficacy aspirin prevention thrombotic graft occlusion coronary artery bypass grafting CABG dosage time window administration Early late graft patency prospective double-blind placebo-controlled trial aspirin mg daily hour CABG METHODS RESULTS Angiographic graft patency week patients year patients CABG early vein graft occlusion rate aspirin placebo graft occlusion rate continued aspirin placebo New graft occlusion week year common patients aspirin placebo protective effect aspirin occlusion subgroups graft type graft flow diameter recipient artery location grafted artery endarterectomy Mean chest tube blood loss first hours ml aspirin group ml placebo group Red cell transfusion requirements ml aspirin group ml placebo group NS reoperation rate aspirin group placebo group CONCLUSIONS Immediate postoperative administration aspirin mg early graft patency continued usage occlusion year CABG Postoperative blood loss similar groups aspirin nonsignificant rate reoperation